ISHD Hemodialysis University™
Chicago, IL USA  September 9-10, 2016
Access to the majority of these talks requires membership-at-large in the ISHD or key zone status at HDCN. Access to talks marked "free" is open to all registered users of HDCN.
Critical Solutions for Dialysis Care
What do new randomized BP studies show regarding CKD?
Jeffrey M. Turner
Blood Pressure and Volume Control with Frequent Dialysis Schedules
Rita Suri, MD
Panel Discussion
Drs. Turner, & Suri
Is it Heart Failure or Fluid Overload?
Peter A. McCullough, MD
Panel Discussion
Patient Reported Outcomes
Mark Unruh, MD
Future Directions in Patient Reported Outcomes - Getting at the stuff people feel
Christopher McIntyre, MD
Panel Discussion
Drs. Unruh, and McIntyre
Vascular Access Exam and Monitoring
Kari Matos, RN
Volume Assessment. Old and New Techniques
Julie Ann Lawrence, RN(EC)
Approach to the Unresponsive Patient
Sylvia Zuidema, RN
Panel Discussions
Drs. Matos, Lawrence, and Zuidema
Going from Zero to One - Starting out with Home Hemodialysis
Brent W. Miller, MD, and Michael A. Kraus MD
New Methods of Delivering Iron to Dialysis Patients
Steven Fishbane, MD
Questions and Answers
Changing Treatment Paradigms in the Management of Chronic Hyperkalemia
Matthew R. Weir, MD
Questions and Answers
Treatment of Hepatitis C Virus in Dialysis Patients
David Roth, MD
Questions and Answers
Acid-base Disorders in CKD
Jose A.L. Arruda, MD
Equivalent Phosphorus Binding Dose and Phosphorus Removal
John T. Daugirdas, MD
Case Reports
Christopher McIntyre, MD
Panel Discussion
Drs. Arruda, Daugirdas, and McIntyre
Unique Patient Populations with ESRD: Malnourished and Morbidly Obese
Klemens B. Meyer, MD
HIF Stabilizers in Anemia Treatment
Steven Fishbane, MD
Panel Discussion
Drs. Fishbane, and Meyer
Welcome Remarks
Madhukar Misra, MD

Jose A.L. Arruda, MD
Keeton Professor Of Medicine
Chief Of Nephrology
University Of Illinois At Chicago

John T. Daugirdas, MD (Course Director)
Clinical Professor of Medicine
University of Illinois at Chicago School of Medicine
Chicago, Illinois. USA

Steven Fishbane, MD
Chief of Nephrology
Department of Medicine
North Shore University Hospital

Julie Ann Lawrence, RN
Nurse practitioner
Regional Renal Program
London Health Sciences Centre
London, Canada Area

Kari Matos, RN
Registered Nurse
London Health Sciences Centre
London, Canada Area

Klemens B. Meyer, MD
Medical Director
Tufts Medical Center
Boston, MA, USA

Madhukar Misra, MD (ISHD President and Course Director)
Professor of Medicine,
University of Missouri Columbia,
School of Medicine. Columbia, MO

Sylvia Zuidema, RN
Nurse Practitioner
Northern Alberta Renal Program
Royal Alexandra Hospital
Edmonton, AB

This educational activity is an video recording with accompanying slides of a live presentation held on September 9-10, 2016, at Chicago, IL USA.

Continuing medical education credit is not available for this on-line archive, but several sessions will be made available for enduring material CME and CEU, as prepared by Medical Education Resources.

To view this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from is useful but not necessary to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the slide handouts.

Program Overview:

Target Audience:
This program is intended for practicing Nephrologists, nephrology fellows, dialysis technologists, interventional nephrologists, vascular access surgeons, and health professionals involved in dialysis programs.
Disclosure Policy:
It is the policy of the ISHD and HDCN that speakers with potential conflicts of interest disclose these at the time of presentation.

Off-label/investigational Use:
Because this course is meant to educate physicians with what is currently in use and what may be available in the future, there may be "off-label" use discussed in the presentations. Speakers have been requested to inform the audience when off-label use is being discussed.

The policy statements of HDCN are listed on this page.